Gregory P Kalemkerian

5PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Jul 14, 2025
The Art of the Art of Oncology.

Mikkael A Sekeres, Gregory A Abel, Timothy Gilligan

|Nov 20, 2024
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.

Humera Khurshid, Nofisat Ismaila, Millie Das

|Nov 20, 2024
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.

Gregory P Kalemkerian, Humera Khurshid, Nofisat Ismaila

|Oct 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.

Humera Khurshid, Nofisat Ismaila, Jessica Bian

Pageof 1